Health Report Early dementia signs from the body not the brain
13 snips
Mar 7, 2025 Darrell Mitchell, a late-life type 1 diabetes advocate, shares his unique journey, shedding light on rising diagnoses in adults. Sarah Trobe, National Director of the National Eating Disorders Collaboration, discusses the intricate concerns surrounding GLP-1 medications, especially for those with eating disorders. They explore alarming findings linking early signs of dementia to weight and lipid changes. The conversation emphasizes the importance of early detection and holistic approaches to health, urging better screening and awareness.
AI Snips
Chapters
Transcript
Episode notes
GLP-1s and Eating Disorders
- Doctors should screen patients for eating disorders before prescribing GLP-1 weight loss drugs.
- This is because GLP-1s may worsen existing or trigger new eating disorders.
GLP-1 Contraindications
- GLP-1 medications are contraindicated for atypical anorexia.
- For other eating disorders, carefully consider their impact on treatment and prioritize holistic health.
Early Dementia Predictors
- Physical changes like weight loss and lipid changes can predict dementia up to a decade in advance.
- These may be early symptoms of brain changes rather than direct causes.